The First Florida Patient to Receive Biogen’s Aduhelm for Alzheimer’s Disease
Jeffrey Gelblum, MD, a board-certified neurologist with First Choice Neurology and Neuro2Go, the nation’s largest neurology practice, treated the first patient in Florida with Biogen’s Aduhelm (aducanumab), an infusion treatment for early-stage Alzheimer’s patients. Aduhelm decreases amyloid plaque in the brain, which is a marker for Alzheimer’s disease. Florida’s first Aduhelm patient is a middle-aged …
The First Florida Patient to Receive Biogen’s Aduhelm for Alzheimer’s Disease Read More »